Helpline 07939 046 030
Freephone 0300 102 17 22*

World At Her Feet

21 August 2019

World At Her Feet

Christina has NF2, and has written a moving blog that is partly about living with the condition, and partly chronicling her travel adventures. The following is a post from her blog, and the images are from her travels. 

Sometimes i forget what my life used to be like...

What did I worry about before brain tumours came into the picture?

What was it like being able to hear people whisper?

How nice was it to not hear ringing in my ears?

It’s so strange t think back on just three years ago when I never even considered having an MRI and thought I had at least 50 more years before hearing tests would become a routine part of my life.

I can’t believe how quickly this has become normal to me.

A year ago, the thought of my tumours growing terrified me. Like even the tiniest growth made me fall apart.

Having MRI’s and hearing tests every 3-motnhs left us on a constant emotional rollercoaster. We were living our lives a few months at a time, and with each new round of scans it would rest again.

But somehow, miraculously, it doesn’t feel like a crisis anymore. This is just my life now.

Over the last year, my MRIs have shown consistent growth on the tumo9ur affecting my food ear, but nothing significant. My doctor even let me take a 6-month break between tests last time!

That may not sound very big, but for me, it made a huge difference. I finally had a chance to stop worrying about results for a bit. It broke the cycle.

After my wonderful break, it was time for my most recent round of scans.

For results to be truly good, my tumours would need to be gone. My hearing would need to be restored and tinnitus silenced. I would need to be cured.

Of course, that’s not my life anymore. My good news bar has substantially lowered.

It turns out my larger tumour has grown again. My hearing is stable though, and we found out the rest of my body (other than my spine) is tumour-free.

But because of the tumour growth, I’ll have to start treatment again in the not so distant future. So, the results were mixed. Not exactly good but not too bad either.

Yet somehow, I left my doctor feeling utter relief. When not even a year ago I probably would have left my appointment in tears.

Gradually, emotionally, somehow… I’ve adjusted. Bad news doesn’t feel quite as big, and I’ve come to accept that this what my life looks like now.

Last December I wrote a post called, “The Life You Almost Lived”. I wrote it when my tumours initially started to grow after stopping treatment.

Everything felt overwhelming. I thought my happiness level had peaked- like each year was going to get harder and harder.

Physically that’s probably true. My disorder is progressive, so it has no choice but to get worse over time. But how handle it emotionally and mentally WILL get better.

Somehow through all of this- because of this all this, I have managed to become truly happy.

Travelling has served as an invaluable distraction this year, and it’s shown me the importance of living beyond my condition. Of pushing myself past my limitations and letting my life be more than just what happens in between my doctor appointments.

Instead of offering the usual “good luck” or “praying for good news,” a wise relative of mine said the following phrase to us before getting my results last week: “I hope that the more you learn, the less scary it becomes.” Her daughter is currently battling cancer, so their family is all to familiar with dealing with this world.

As we walked out of the hospital that day it thought about her well wishes and how accurate they are for us. All of this has become less scary. A lot less scary. And as scariness has waned, we’ve learned to enjoy our live within the circumstances we’ve been dealt.

Somehow, over time, our new normal doesn’t look so bad after all.

Filter News

Filter by Date
Category
Reset

London Marathon 2023 Team NTUK

Congratulations to Team NTUK!

Read More

New ways to treat NF1 tumours with existing drugs

Researchers at the Living Systems Institute, University of Exeter, UK are researching new ways to treat NF1 tumours

Read More

Easter Message

A message from Karen, our Charity Director, wishing you a very Happy Easter!

Read More

Equality, Diversity and Inclusion in the Workplace

Nerve Tumours are here to support you in the workplace: iNForm; workplace equality research & creating an inclusive workplace

Read More

Wayne’s World of Marathons

Read about Wayne's world: marathons, running a wedding fayre business with wife Leanne and their son Harley who has NF1

Read More

Team NTUK London Marathon 2023

Meet some of our runners and read their inspiring marathon motivation stories

Read More

Pip’s London Marathon

Pip describes life with NF1 & limited vision and his motivation to run the London Marathon

Read More

The Scottish Parliament Rare Disease Day Online Reception 15/03/2023

NTUK attended the Scottish Parliament Rare Disease Day online reception

Read More

Support Derry’s and Dan’s Marathon Run for NTUK

Dan and Derry will be taking on the London Marathon in support of Nerve Tumours UK

Read More

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK